Slush 2024: Meet the 3 Finalist Startups of Slush100
SP 🇪🇸   EN 🇬🇧
Newsletter
 

Slush2024: These are the three finalist startups of Slush100

Three startups have been selected for the final that will take place this Thursday 21st on the Founder Stage at Slush. These are DevAlly (Ireland/USA); Mohana (Canada) and Oasys Now (The Netherlands).

Slush2024: Ya están las tres startups finalistas de Slush100, Slush

This Wednesday marked the first day of Slush 2024, the main event that brings together the European ecosystem in Helsinki. Among the varied activities that took place, the Pitch competition of the 20 semi-finalist startups from the Slush100 contest took place on the Founder Stage, which had to face an international level jury.

Finally, three startups were selected for the final that will take place this Thursday, 21st on the Founder Stage at Slush. These include DevAlly (Ireland/USA); Mohana (Canada) and Oasys Now (Netherlands).

If you want to see which of the three startups will take first place, you can follow the live broadcast from Helsinki at slush.org/livestream 

Slush100 Jury at Slush 2024 Slush

Follow us on: Google News


What are the prizes?

In this 2024, the winner of Slush 100 will receive as a prize an investment of €1,000,000 from the leading early-stage investment funds in Europe: General Catalyst and Cherry Ventures.

Here we leave you with what each of the three finalists does:

1.- DevAlly: Makes accessibility easy and eliminates the manual work of regulatory compliance. It allows you to create products that not only meet audits, but are also inclusive and functional for everyone.

2.- Mohana: A Healthtech that promotes mental well-being by connecting users with therapists and offering educational tools to improve emotional health.

3.- Oasys Now: A platform that facilitates patients in managing their health data and searching for treatments suitable for their medical profile. By centralizing and analyzing users' health information, the platform offers options for innovative and personalized treatments, contributing to the advancement of medical research and improving access to health care.